Alkermes Medicines & Focus: Cancer

We are actively researching new immuno-oncology agents for cancer patients in tumor types where we see significant need and opportunity for new treatment options.

Videos from this campaign

Content from this campaign

Health & Healthcare

Alkermes Pauses To Recognize National Ovarian Cancer Awareness Month
September is Ovarian Cancer Awareness Month. We stand in solidarity with patients, caregivers and family members whose lives have been impacted by Ovarian Cancer.

Health & Healthcare

Clinical Trials Integral to Providing More Treatment Options for Platinum-Resistant Ovarian Cancer (PROC)
Patients diagnosed with platinum-resistant Ovarian Cancer (PROC) often face poor prognosis due to the limited treatment options.

Responsible Business & Employee Engagement

Former Oncology Nurse Finds a New Path To Improve Patients' Lives
Meet Michele, an Alkermes employee who uses her past experience as an oncology nurse to aid in her personal mission of helping to improve patients’ lives through research.

Health & Healthcare

Alkermes Looks To Fill Cancer Treatment Gaps With New Immune Pathways
A conversation with Craig Hopkinson

Health & Healthcare

Maintaining a Healthy Lifestyle During Cancer Treatments
August is #NationalWellnessMonth, centered around self-care, stress management and healthy routines.

Health & Healthcare

Alkermes Remains Committed to Oncology Innovation
On the heels of ASCO22, we remain committed to innovating in the oncology space, particularly for cancers with high unmet needs, like platinum-resistant ovarian cancer.

Health & Healthcare

Tips to Improve Mental Well-Being
It is estimated that up to one-third of cancer patients in hospitals experience negative mental health effects.

Responsible Business & Employee Engagement

Alkermes Celebrates National Women's Health Week by Reminding You Why Regular Cancer Screenings Are Vital
This National Women’s Health Week, Alkermes’ Director of Corporate and R&D Communications, Gretchen Murphy, shares her personal story and why regular cancer screenings are vital.

Health & Healthcare

Alkermes Recognizes Minority Cancer Awareness Month
While the industry has made great strides in cancer research and treatments, minority groups in the U.S. continue to bear a greater burden of cancers compared with others.

Health & Healthcare

Alkermes Head of Medical Affairs Highlights the Importance of Patient-Focused Drug Development
In a recent article for Boston Business Journal, Dr. Kanchan Relwani highlights the importance of patient-focused drug development and how we seek to incorporate the patient voice into all we do.
Alkermes logo

More from Alkermes

  1. Alkermes: Corporate Responsibility
    We strive to have a positive impact on our employees, members of our communities, our local environment and society at large. We support research...

  2. Alkermes: Diversity, Inclusion & Belonging
    Alkermes is committed to diversity, inclusion and belonging in various aspects of our business. We are purposeful about creating an environment that...

  3. Alkermes Medicines & Focus: Serious Mental Illness
    We are committed to addressing unmet needs in serious mental illness through the development of therapeutic options to support adults living with...

  4. Alkermes Medicines & Focus: Cancer
    We are actively researching new immuno-oncology agents for cancer patients in tumor types where we see significant need and opportunity for new...

  5. Alkermes Inspiration Grants®
    Since 2016, the Alkermes Inspiration Grants ® program has awarded more than $4 million in funding to innovative programs that support the...

  6. Alkermes Medicines & Focus: Addiction
    We have been at the forefront of addiction medicine for more than a decade, seeking to help people living with alcohol dependence and opioid...